Laboratory for Biomaterials & Graft Technology, Istituto di Fisiologia Clinica CNR, Massa, 54100, Italy.
Fondazione Toscana Gabriele Monasterio (FTGM), Massa, 54100, Italy.
J Biomed Mater Res B Appl Biomater. 2019 May;107(4):951-964. doi: 10.1002/jbm.b.34189. Epub 2018 Sep 3.
Highly porous small-diameter vascular grafts (SDVGs) prepared with elastomeric materials such as poly(ether urethane) (PEtU)-polydimethylsiloxane (PEtU-PDMS) are capable to biodegrade but may develop aneurismal dilatation. Through a compliance/patency assessment with ultrasound techniques, the current study investigated the functionality, in terms of patency and endothelialization, of a highly flexible and porous Nitinol mesh incorporated into PEtU-PDMS SDVGs in a sheep carotid model. Nitinol-PEtU-PDMS grafts with an internal diameter (ID) of 4 mm were manufactured by spray, phase-inversion technique. Compliance tests were performed by ultrasound (US) imaging using a high-resolution ultrasound diagnostic system. Ten adult sheep were implanted with 7 cm long grafts. The results of this study demonstrated an almost complete neointima luminal coverage in transmurally porous grafts reinforced with the Nitinol meshes after 6 months of implantation. Additionally, ultrasound has been used to quantitatively assess and monitor hemodynamic variables in an experimental model of synthetic vascular graft replacement. The use of reinforced PEtU-PDMS grafts may accelerate the endothelialization process of relatively long grafts, such as those needed for aortocoronary bypass. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 951-964, 2019.
用弹性材料如聚醚氨酯(PEtU)-聚二甲基硅氧烷(PEtU-PDMS)制备的高多孔小直径血管移植物(SDVG)可生物降解,但可能会发生动脉瘤扩张。通过超声技术的顺应性/通畅性评估,本研究在绵羊颈动脉模型中研究了高度灵活和多孔的 Nitinol 网纳入到 PEtU-PDMS SDVG 中的功能,即在通畅性和内皮化方面的功能。内径(ID)为 4mm 的 Nitinol-PEtU-PDMS 移植物通过喷涂、相转化技术制造。顺应性测试通过使用高分辨率超声诊断系统的超声(US)成像进行。10 只成年绵羊植入了 7cm 长的移植物。这项研究的结果表明,在植入 6 个月后,在 Nitinol 网增强的透壁多孔移植物中,几乎完全覆盖了新生内膜管腔。此外,超声已被用于定量评估和监测合成血管移植物置换实验模型中的血液动力学变量。使用增强型 PEtU-PDMS 移植物可能会加速相对较长的移植物(如用于主动脉冠状动脉旁路移植术的移植物)的内皮化过程。2018 年威利父子公司。J 生物医学材料研究部分 B:应用生物材料 107B:951-964,2019 年。